-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Tenaya Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2025.
- Tenaya Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$23.1M, a 19.4% increase year-over-year.
- Tenaya Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$90.5M, a 11.3% increase from 2023.
- Tenaya Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$102M, a 2.25% increase from 2022.
- Tenaya Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$104M, a 71.7% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)